Similar articles

• Management of venous thromboembolism.

  [No authors listed] [No authors listed] Lancet. 1988 Feb 6;1(8580):275-7. Lancet. 1988. PMID: 2893086 Clinical Trial. No abstract available.
• Anticoagulant therapy for venous thromboembolism.

  Raskob GE, Carter CJ, Hull RD. Raskob GE, et al. Prog Hemost Thromb. 1989;9:1-27. Prog Hemost Thromb. 1989. PMID: 2643814 Review. No abstract available.
• Heparin-induced decrease in circulating antithrombin-III.

  Marciniak E, Gockerman JP. Marciniak E, et al. Lancet. 1977 Sep 17;2(8038):581-4. doi: 10.1016/s0140-6736(77)91429-5. Lancet. 1977. PMID: 71399
• [Use of heparin and oral anticoagulants to prevent and treat deep venous thrombosis and pulmonary embolism].

  Hamerschlak N, Rosenfeld LG. Hamerschlak N, et al. Arq Bras Cardiol. 1996 Sep;67(3):209-13. Arq Bras Cardiol. 1996. PMID: 9181717 Review. Portuguese. No abstract available.
• Heparin in the treatment of venous thrombo-embolic disease: administration, control and results.

  O'Sullivan EF, Hirsh J, McCarthy RA, de Gruchy GC. O'Sullivan EF, et al. Med J Aust. 1968 Jul 27;2(4):153-9. doi: 10.5694/j.1326-5377.1968.tb29378.x. Med J Aust. 1968. PMID: 5670883 No abstract available.